| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | ||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development (includes share-based compensation expense) | ||||||
4,953 | - | - | - | 7,683 | ||
General and administrative (includes share-based compensation expense) | ||||||
6,088 | - | - | - | 1,201 | ||
Total operating expenses | ||||||
11,041 | 395 | 67 | - | 8,884 | ||
Interest expense | ||||||
376 | - | - | - | - | ||
Other (income)/expense, net | ||||||
221 | - | - | - | 43 | ||
Franchise taxes | ||||||
- | 24 | 24 | - | - | ||
Loss from operations | ||||||
- | -419 | -92 | - | - | ||
Interest income | ||||||
- | 683 | 341 | - | - | ||
Loss before provision for income taxes | ||||||
-11,196 | 263 | 249 | - | -8,841 | ||
Income tax expense | ||||||
100 | 138 | 66 | - | 8 | ||
Operating costs | ||||||
- | - | - | 0 | - | ||
Net loss | ||||||
-11,296 | 125 | 182 | -0 | -8,849 | ||
Net loss per common share - basic and diluted | ||||||
-0.28 | 0.05 | 0.02 | 0.00 | -0.24 | ||
Weighted-average common shares outstanding – basic and diluted | ||||||
41,035 | 11,500 | 11,500 | 2,500 | 36,735 | ||
Weighted average shares outstanding of non-redeemable common stock | ||||||
- | 2,875 | 2,875 | - | - | ||
Basic and diluted net loss per share, non-redeemable common stock | ||||||
- | -0.14 | -0.02 | - | - | ||